Effects of a low-energy diet and an insulin-sensitizing agent on ambulatory blood pressure in overweight hypertensive patients

Journal of Hypertension

Volumn 18, Issue 10, 2000, Pages 1451-1455

  Kawano, Yuhei ^a   Okuda, Naoki ^a   Minami, Junichi ^a   Takishita, Shuichi ^a   Omae, Teruo ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Ambulatory blood pressure monitoring; Diet; Hypertension; Insulin; Obesity; Troglitazone

Indexed keywords

GLUCOSE; INSULIN; LIPID; TRIACYLGLYCEROL; TROGLITAZONE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LOW FAT DIET; MALE; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0033788777     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018100-00013     Document Type: Article

References (40)

1. The relationship between body weight and blood pressure
2. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
3. Role of insulin resistance in human disease
4. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease
5. Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals
6. Diet and exercise in the treatment of obesity: Effects of three interventions on insulin resistance
7. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia
8. Sustained hyperinsulinemia increases arterial pressure in conscious rats
9. In defense of insulin: A critique of syndrome X
10. Lack of association between blood pressure and insulin in patients with insulinoma
11. Microvascular function relates to insulin sensitivity and blood pressure in normal subjects
12. Troglitazone, an insulin enhancer, improves metabolic control in NIDDM patients
13. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial
14. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone
15. Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives
16. Antihypertensive effects of CS-045 treatment in obese Zucker rats
17. Attenuation of hypertension by insulin-sensitizing agents
18. Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats
19. Evidence against a role of insulin in hypertension in spontaneously hypertensive rats: CS-045 does not lower blood pressure despite improvement of insulin resistance
20. Clinical value of ambulatory blood pressure monitoring
21. Effects of magnesium supplementation in hypertensive patients: Assessment by office, home, and ambulatory blood pressures
22. Effects of alcohol restriction on 24-hour ambulatory blood pressure in Japanese men with hypertension
23. The accuracy and performance of the A and TM2421, a new ambulatory blood pressure monitoring device based on the cuff oscillometric and Korotkoff sound technique
24. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder
25. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
26. Lifestyle modifications in the management of hypertension: Effects and limitations
27. Cardiac and glycemic benefits of troglitazone treatment in NIDDM
28. Troglitazone, an insulin sensitizer, increases forearm blood flow in humans
29. Mechanisms of vasorelaxation induced by troglitazone, a novel antidiabetic drug, in the porcine coronary artery
30. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors
31. Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive obese women
32. Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects
33. Obesity, the sympathetic nervous system, and essential hypertension
34. Renal and cardiovascular mechanisms of hypertension in obesity
35. Acute and chronic effects of a hypocaloric diet on 24-hour blood pressure, heart rate, and heart rate variability in mildly-to-moderately obese patients with essential hypertension
36. Serun immunoreactive-leptin concentrations in normal-weight and obese humans
37. The obese gene product, leptin: Possible role in obesity-related hypertension in adolescents
38. Sympathetic and cardiorenal actions of leptin
39. Chronic leptin infusion increases arterial pressure
40. Role of leptin in obesity-related hypertension [abstract]